995
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Assessment of whole blood platelet aggregation in patients with cirrhosis: challenges and opportunities

, , &
Article: 2178823 | Received 01 Jan 2023, Accepted 06 Feb 2023, Published online: 20 Feb 2023

References

  • Scavone M, Podda GM, Tripodi A, Cattaneo M. Whole blood platelet aggregation measurement by multiplate: potential diagnostic inaccuracy of correcting the results for the sample platelet count. Platelets. 2023;34(1):2156493. doi:10.1080/09537104.2022.2156493.
  • Zanetto A, Campello E, Bulato C, Gavasso S, Farinati F, Russo FP, Tormene D, Burra P, Senzolo M, Simioni P. Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death. J Hepatol. 2022;77(3):660–3. doi:10.1016/j.jhep.2022.03.009.
  • Qi XT, Wan F, Lou Y, Ye B, Wu D. The mean platelet volume is a potential biomarker for cirrhosis in chronic hepatitis B virus infected patients. Hepatogastroenterology. 2014;61(130):456–459.
  • Wang X, Jiang W, Li F, Hua F, Zhan Y, Li Y, Ji L, Zou S, Min Z, Song D, et al. Abnormal platelet kinetics are detected before the occurrence of thrombocytopaenia in HBV-related liver disease. Liver Int. 2014;34(4):535–543. doi:10.1111/liv.12309.
  • Luzzatto G, de Franchis G, Fabris F, Gerunda GE, Girolami A. Increased proportion of giant platelets and platelet distribution width are better indicators of altered platelet homeostasis than mean platelet volume in liver cirrhosis. Folia Haematol Int Mag Klin Morphol Blutforsch. 1988;115(5):719–726.
  • Giannini EG, Moscatelli A, Brunacci M, Zentilin P, Savarino V. Prognostic role of mean platelet volume in patients with cirrhosis. Dig Liver Dis. 2016;48(4):409–413. doi:10.1016/j.dld.2015.10.018.
  • Jorgensen B, Fischer E, Ingeberg S, Hollaender N, Ring-Larsen H, Henriksen JH. Decreased blood platelet volume and count in patients with liver disease. Scand J Gastroenterol. 1984;19(4):492–496. doi:10.1080/00365521.1984.12005758.
  • Han L, Han T, Nie C, Zhang Q, Cai J. Elevated mean platelet volume is associated with poor short-term outcomes in hepatitis B virus-related acute-on-chronic liver failure patients. Clin Res Hepatol Gastroenterol. 2015;39(3):331–339. doi:10.1016/j.clinre.2014.10.006.
  • Zanetto A, Pelizzaro F, Campello E, Bulato C, Balcar L, Gu W, Gavasso S, Saggiorato G, Zeuzem S, Russo FP, et al. Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis. J Hepatol. 2022;78(2):301–311. doi:10.1016/j.jhep.2022.09.005.
  • Campello E, Zanetto A, Bulato C, Maggiolo S, Spiezia L, Russo FP, Gavasso S, Mazzeo P, Tormene D, Burra P, et al. Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. Liver Int. 2021;41(10):2455–2466. doi:10.1111/liv.15001.
  • Karpatkin S. Heterogeneity of human platelets. VI. Correlation of platelet function with platelet volume. Blood. 1978;51(2):307–316. doi:10.1182/blood.V51.2.307.307.
  • Pradella P, Bonetto S, Turchetto S, Uxa L, Comar C, Zorat F, De Angelis V, Pozzato G. Platelet production and destruction in liver cirrhosis. J Hepatol. 2011;54(5):894–900. doi:10.1016/j.jhep.2010.08.018.
  • Raparelli V, Basili S, Carnevale R, Napoleone L, Del Ben M, Nocella C, Bartimoccia S, Lucidi C, Talerico G, Riggio O, et al. Low-grade endotoxemia and platelet activation in cirrhosis. Hepatology. 2017;65(2):571–581. doi:10.1002/hep.28853.
  • Zanetto A, Campello E, Bulato C, Gavasso S, Saggiorato G, Shalaby S, Burra P, Angeli P, Senzolo M, Simioni P. Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections. JHEP Rep. 2022;4(7):100493. doi:10.1016/j.jhepr.2022.100493.
  • Zanetto A, Rinder HM, Campello E, Saggiorato G, Deng Y, Ciarleglio M, Wilson FP, Senzolo M, Gavasso S, Bulato C, et al. Acute kidney injury in decompensated cirrhosis is associated with both hypo-coagulable and hyper-coagulable features. Hepatology. 2020;72(4):1327–1340. doi:10.1002/hep.31443.
  • Zanetto A, Senzolo M, Campello E, Bulato C, Gavasso S, Shalaby S, Gambato M, Vitale A, Cillo U, Farinati F, et al. Influence of hepatocellular carcinoma on platelet aggregation in cirrhosis. Cancers (Basel). 2021;13(5):1150. doi:10.3390/cancers13051150.
  • Zermatten MG, Fraga M, Moradpour D, Bertaggia Calderara D, Aliotta A, Stirnimann G, De Gottardi A, Alberio L. Hemostatic alterations in patients with cirrhosis: from primary hemostasis to fibrinolysis. Hepatology. 2020;71(6):2135–2148. doi:10.1002/hep.31201
  • Zanetto A, Campello E, Burra P, Senzolo M, Simioni P. Increased platelet ratio in patients with decompensated cirrhosis indicates a higher risk of portal vein thrombosis. Liver Int. 2022;77:S358–359. doi:10.1016/S0168-8278(22)01072-8.
  • Lisman T, Bongers TN, Adelmeijer J, Janssen HL, de Maat MP, de Groot PG, Leebeek FW. Elevated levels of von willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology. 2006;44(1):53–61. doi:10.1002/hep.21231.
  • Shalaby S, Zanetto A, Campello E, Gavasso S, Barbiero G, Battistel M, Feltracco P, Bizzaro D, Burra P, Simioni P, et al. Reply to “peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis”. Platelets. 2022;33(7):1104–1106. doi:10.1080/09537104.2022.2060499.
  • Queck A, Carnevale R, Uschner FE, Schierwagen R, Klein S, Jansen C, Meyer C, Praktiknjo M, Thomas D, Strassburg C, et al. Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS. Gut. 2020;69(8):1535–1536. doi:10.1136/gutjnl-2019-319044.